PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
7825491-3	1994	AHH activity, expressed as nM 3-hydroxy benzopyrene formed/10(6) cells/h of incubation, was similar in young and elderly non-smokers (elderly = 6.7 +/- 1.8; young = 9.1 +/- 0.9; p > 0.05).	3-hydroxybenzo(a)pyrene	30-51	cytochrome P450 family 1 subfamily B member 1	Homo sapiens	0-3
17126885-2	2007	Two main metabolites of BaP, benzo[a]pyrene-1,6-quinone (BP1,6-quinone) and 3-hydroxybenzo[a]pyrene (3-OHBP) were identified by high performance liquid chromatography (HPLC) with standards.	3-hydroxybenzo(a)pyrene	76-99	prohibitin 2	Homo sapiens	24-27
17126885-2	2007	Two main metabolites of BaP, benzo[a]pyrene-1,6-quinone (BP1,6-quinone) and 3-hydroxybenzo[a]pyrene (3-OHBP) were identified by high performance liquid chromatography (HPLC) with standards.	3-hydroxybenzo(a)pyrene	101-107	prohibitin 2	Homo sapiens	24-27
17126885-10	2007	The highest accumulation of BP1,6-quinone and 3-OHBP were reduced by nearly 10% in the degradation experiments, which further proved that the combined degradation system was more effective as far as joint toxicity of BaP and its metabolites are concerned.	3-hydroxybenzo(a)pyrene	46-52	prohibitin 2	Homo sapiens	217-220
15929889-3	2005	At concentrations > 0.15 microM, 3-OH-BaP inhibited its own sulfonation in cytosol fractions that were genotyped for SULT1A1 variants, as well as with expressed SULT1A1*1, SULT1A1*2, and SULT1E1, but not with SULT1A3 or SULT1B1.	3-hydroxybenzo(a)pyrene	36-44	sulfotransferase family 1A member 1	Homo sapiens	120-127
15929889-3	2005	At concentrations > 0.15 microM, 3-OH-BaP inhibited its own sulfonation in cytosol fractions that were genotyped for SULT1A1 variants, as well as with expressed SULT1A1*1, SULT1A1*2, and SULT1E1, but not with SULT1A3 or SULT1B1.	3-hydroxybenzo(a)pyrene	36-44	sulfotransferase family 1A member 1	Homo sapiens	164-171
15929889-3	2005	At concentrations > 0.15 microM, 3-OH-BaP inhibited its own sulfonation in cytosol fractions that were genotyped for SULT1A1 variants, as well as with expressed SULT1A1*1, SULT1A1*2, and SULT1E1, but not with SULT1A3 or SULT1B1.	3-hydroxybenzo(a)pyrene	36-44	sulfotransferase family 1A member 1	Homo sapiens	164-171
15929889-3	2005	At concentrations > 0.15 microM, 3-OH-BaP inhibited its own sulfonation in cytosol fractions that were genotyped for SULT1A1 variants, as well as with expressed SULT1A1*1, SULT1A1*2, and SULT1E1, but not with SULT1A3 or SULT1B1.	3-hydroxybenzo(a)pyrene	36-44	sulfotransferase family 1E member 1	Homo sapiens	190-197
15929889-3	2005	At concentrations > 0.15 microM, 3-OH-BaP inhibited its own sulfonation in cytosol fractions that were genotyped for SULT1A1 variants, as well as with expressed SULT1A1*1, SULT1A1*2, and SULT1E1, but not with SULT1A3 or SULT1B1.	3-hydroxybenzo(a)pyrene	36-44	sulfotransferase family 1A member 3	Homo sapiens	212-219
15929889-3	2005	At concentrations > 0.15 microM, 3-OH-BaP inhibited its own sulfonation in cytosol fractions that were genotyped for SULT1A1 variants, as well as with expressed SULT1A1*1, SULT1A1*2, and SULT1E1, but not with SULT1A3 or SULT1B1.	3-hydroxybenzo(a)pyrene	36-44	sulfotransferase family 1B member 1	Homo sapiens	223-230
15929889-10	2005	The OH-PCBs tested inhibited sulfonation of 3-OH-BaP by SULT1E1, but the order of inhibitory potency was different than for SULT1A1.	3-hydroxybenzo(a)pyrene	44-52	sulfotransferase family 1E member 1	Homo sapiens	56-63
15929889-12	2005	The OH-PCBs tested were generally poor inhibitors of SULT1A3- and SULT1B1-dependent activity with 3-OH-BaP.	3-hydroxybenzo(a)pyrene	98-106	sulfotransferase family 1A member 3	Homo sapiens	53-60
15929889-12	2005	The OH-PCBs tested were generally poor inhibitors of SULT1A3- and SULT1B1-dependent activity with 3-OH-BaP.	3-hydroxybenzo(a)pyrene	98-106	sulfotransferase family 1B member 1	Homo sapiens	66-73
15269185-7	2004	Studies of 3-OH-BaP sulfonation by expressed human SULT1A1*1, SULT1A1*2, SULT1B1, and SULT1E1 showed that triclosan inhibited the activities of each of these purified enzymes with IC50 concentrations between 2.09 and 7.5 microM.	3-hydroxybenzo(a)pyrene	11-19	sulfotransferase family 1A member 1	Homo sapiens	51-58
15269185-7	2004	Studies of 3-OH-BaP sulfonation by expressed human SULT1A1*1, SULT1A1*2, SULT1B1, and SULT1E1 showed that triclosan inhibited the activities of each of these purified enzymes with IC50 concentrations between 2.09 and 7.5 microM.	3-hydroxybenzo(a)pyrene	11-19	sulfotransferase family 1A member 1	Homo sapiens	62-69
15269185-7	2004	Studies of 3-OH-BaP sulfonation by expressed human SULT1A1*1, SULT1A1*2, SULT1B1, and SULT1E1 showed that triclosan inhibited the activities of each of these purified enzymes with IC50 concentrations between 2.09 and 7.5 microM.	3-hydroxybenzo(a)pyrene	11-19	sulfotransferase family 1B member 1	Homo sapiens	73-80
15269185-7	2004	Studies of 3-OH-BaP sulfonation by expressed human SULT1A1*1, SULT1A1*2, SULT1B1, and SULT1E1 showed that triclosan inhibited the activities of each of these purified enzymes with IC50 concentrations between 2.09 and 7.5 microM.	3-hydroxybenzo(a)pyrene	11-19	sulfotransferase family 1E member 1	Homo sapiens	86-93
11302939-2	2001	3-Hydroxybenzo(a)pyrene was a good substrate for adenosine 3"-phosphate 5"-phosphosulfate (PAPS)-sulfotransferase and UDP-glucuronosyltransferase in cytosol or microsomes prepared from intestinal mucosa.	3-hydroxybenzo(a)pyrene	0-23	UDP-glucuronosyltransferase	Ictalurus punctatus	118-145
8806846-7	1996	Comparable 3-OHBaP excretion profiles were obtained after injection of BaP or a mixture of BaP metabolites.	3-hydroxybenzo(a)pyrene	11-18	prohibitin 2	Rattus norvegicus	71-74
17449565-2	2008	In this context, the analytical and diagnostical reliability of 3-hydroxybenzo[a]pyrene (3OH-BaP) as a biomarker of internal exposure to PAHs was established.	3-hydroxybenzo(a)pyrene	64-87	prohibitin 2	Homo sapiens	93-96
12649394-0	2003	Role of cytochrome P4501B1 in benzo[a]pyrene bioactivation to DNA-binding metabolites in mouse vascular smooth muscle cells: evidence from 32P-postlabeling for formation of 3-hydroxybenzo[a]pyrene and benzo[a]pyrene-3,6-quinone as major proximate genotoxic intermediates.	3-hydroxybenzo(a)pyrene	173-196	cytochrome P450, family 1, subfamily b, polypeptide 1	Mus musculus	8-26
12633750-8	2003	This is followed by oxygen transfer to the most electropositive carbon atoms, C-6, C-1, and C-3, with formation of 6-OHBP (and its quinones), 1-OHBP, and 3-OHBP, respectively, or the most electropositive 4,5-, 7,8-, and 9,10- double bonds, with formation of BP 4,5-, 7,8-, or 9,10-oxide.	3-hydroxybenzo(a)pyrene	154-160	complement C6	Rattus norvegicus	78-81
12633750-8	2003	This is followed by oxygen transfer to the most electropositive carbon atoms, C-6, C-1, and C-3, with formation of 6-OHBP (and its quinones), 1-OHBP, and 3-OHBP, respectively, or the most electropositive 4,5-, 7,8-, and 9,10- double bonds, with formation of BP 4,5-, 7,8-, or 9,10-oxide.	3-hydroxybenzo(a)pyrene	154-160	complement C3	Rattus norvegicus	92-95
7954414-5	1994	BHT and BHA increased UDP-glucuronosyltransferase activities in liver microsomes for p-nitrophenol (236 and 218%, respectively), 3-hydroxybenzo(a)pyrene (246 and 175%, respectively), and androsterone (269 and 152%, respectively).	3-hydroxybenzo(a)pyrene	129-152	UDP glycosyltransferase 2 family, polypeptide B	Rattus norvegicus	22-49
8292743-3	1993	Because 3-hydroxybenzo[a]-pyrene is one of the major metabolites of BP, preparation of 3-fluorobenzo[a]pyrene (3-FBP) was undertaken.	3-hydroxybenzo(a)pyrene	8-32	ECB2	Homo sapiens	113-116
8347144-12	1993	UDP-glucuronosyltransferase (UGT) activities towards 3-OH-BP (UGT1A1) and 4-OH-biphenyl (UGT2B1) were also determined.	3-hydroxybenzo(a)pyrene	53-60	UDP glycosyltransferase 2 family, polypeptide B	Rattus norvegicus	0-27
8347144-12	1993	UDP-glucuronosyltransferase (UGT) activities towards 3-OH-BP (UGT1A1) and 4-OH-biphenyl (UGT2B1) were also determined.	3-hydroxybenzo(a)pyrene	53-60	UDP glycosyltransferase 2 family, polypeptide B	Rattus norvegicus	29-32
8347144-12	1993	UDP-glucuronosyltransferase (UGT) activities towards 3-OH-BP (UGT1A1) and 4-OH-biphenyl (UGT2B1) were also determined.	3-hydroxybenzo(a)pyrene	53-60	UDP glucuronosyltransferase family 1 member A1	Rattus norvegicus	62-68
3311446-1	1987	3-Hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene (3-OH-BP-7,8-diol) was isolated from arylsulfatase/beta-glucuronidase-treated bile of rats to which 3-hydroxybenzo[a]pyrene (3-OH-BP) has been administered.	3-hydroxybenzo(a)pyrene	156-179	glucuronidase, beta	Rattus norvegicus	107-125
1914788-5	1991	3-OH-BP-UDPGT was not significantly induced by any of the chemicals in either genetic cross.	3-hydroxybenzo(a)pyrene	0-7	UDP glucuronosyltransferase 1 family, polypeptide A1	Mus musculus	8-13
3124855-4	1988	UDP-glucuronosyltransferase (GT) activities towards 3-hydroxybenzo[a]pyrene (GT1) and 4-hydroxybiphenyl (GT2) were present in all the cells.	3-hydroxybenzo(a)pyrene	52-75	UDP glycosyltransferase 2 family, polypeptide B	Rattus norvegicus	0-27
3124855-4	1988	UDP-glucuronosyltransferase (GT) activities towards 3-hydroxybenzo[a]pyrene (GT1) and 4-hydroxybiphenyl (GT2) were present in all the cells.	3-hydroxybenzo(a)pyrene	52-75	UDP glycosyltransferase 2 family, polypeptide B	Rattus norvegicus	29-31
1540958-6	1992	Placental aryl hydrocarbon hydroxylase activity was significantly higher in placentas from which BP-tetrols were extracted [3.9 +/- 2.4 [corrected] (mean +/- SE) pmol 3-hydroxybenzo(a)pyrene mg protein-1 min-1], than among placentas from which BP-tetrols were not extracted (0.4 +/- 0.2 [corrected] pmol 3-hydroxybenzo(a)pyrene mg protein-1 min-1) (P = 0.03, Student"s t test).	3-hydroxybenzo(a)pyrene	167-190	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	10-38
1799222-3	1991	Moreover, since the assay was tailored to directly measure 3-hydroxybenzo(a)pyrene, a metabolite produced by several cytochrome P-450s, it may be more generally applicable than dealkylation assays, which apparently detect only P-450-IA1.	3-hydroxybenzo(a)pyrene	59-82	insulinoma-associated 1	Mus musculus	227-236
3311446-1	1987	3-Hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene (3-OH-BP-7,8-diol) was isolated from arylsulfatase/beta-glucuronidase-treated bile of rats to which 3-hydroxybenzo[a]pyrene (3-OH-BP) has been administered.	3-hydroxybenzo(a)pyrene	57-64	glucuronidase, beta	Rattus norvegicus	107-125
3102438-3	1987	The average basal AHH activity of 29 epidermal cultures in primary culture was 3.9 units (SD, 4.2; range, 0-16.3) (one unit was defined as 1 pmol of 3-hydroxybenzo[a]pyrene formed/mg protein/hr).	3-hydroxybenzo(a)pyrene	149-172	aryl hydrocarbon receptor repressor	Homo sapiens	18-21
3599463-1	1987	To investigate life environmental factors which affect aryl hydrocarbon hydroxylase (AHH) activity, basal and 3-methylcholanthrene(3-MC)-induced AHH activities were determined by the formation of 3-hydroxybenzo(a)pyrene in cultured lymphocytes obtained from 111 healthy male subjects who lived in Fukuoka Prefecture, Japan.	3-hydroxybenzo(a)pyrene	196-219	cytochrome P450 family 1 subfamily B member 1	Homo sapiens	85-88
3599463-1	1987	To investigate life environmental factors which affect aryl hydrocarbon hydroxylase (AHH) activity, basal and 3-methylcholanthrene(3-MC)-induced AHH activities were determined by the formation of 3-hydroxybenzo(a)pyrene in cultured lymphocytes obtained from 111 healthy male subjects who lived in Fukuoka Prefecture, Japan.	3-hydroxybenzo(a)pyrene	196-219	cytochrome P450 family 1 subfamily B member 1	Homo sapiens	145-148
3564534-4	1987	3-Hydroxybenzo[a]pyrene was a major product formed by pulmonary cytochrome P-450MC, in the absence or presence of epoxide hydrolase.	3-hydroxybenzo(a)pyrene	0-23	cytochrome P450, family 1, subfamily a, polypeptide 1	Rattus norvegicus	75-82
2866028-3	1985	Cytochrome P-450 dependent metabolism of benzo[a]pyrene, aldrin and ethoxyresorufin was 43-54% lower than in the parent cell suspension, glucuronidation of 3-hydroxybenzo[a]pyrene (3-OH-BP) and hydrolysis of styrene oxide were increased 1.5- and 1.4-fold, respectively.	3-hydroxybenzo(a)pyrene	156-179	cytochrome P450, family 2, subfamily g, polypeptide 1	Rattus norvegicus	0-16
3085679-3	1986	After topical application of Aroclor 1254 to the skin UDPGT activities towards 1-naphthol, 3-hydroxybenzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol were increased 3-fold and AHH activity was increased 15-fold.	3-hydroxybenzo(a)pyrene	91-114	UDP glucuronosyltransferase 1 family, polypeptide A6A	Mus musculus	54-59
2872038-2	1986	The following enzyme activities were determined: cytochrome P-448-dependent ethoxyresorufin O-deethylase (ERDE) and cytochrome P-450-dependent aldrin epoxidase (AE), and, furthermore, the GT form(s) metabolizing 3-hydroxybenzo(a)pyrene (GT1) and the GT form(s) metabolizing 4-hydroxybiphenyl (GT2).	3-hydroxybenzo(a)pyrene	212-235	cytochrome P450, family 1, subfamily a, polypeptide 2	Rattus norvegicus	49-65
3712488-7	1986	3-Hydroxy-BaP (3-OH) formation was measured fluorometrically as aryl hydrocarbon hydroxylase activity (AHH) in lung microsomes.	3-hydroxybenzo(a)pyrene	0-13	cytochrome P450, family 1, subfamily a, polypeptide 1	Rattus norvegicus	103-106
4053018-7	1985	Intrinsic AHH activities were below the level of detection for all cell lines [less than 1 pmol of 3-hydroxybenzo(a)pyrene (3-OH-BP) formed per min per mg of protein].	3-hydroxybenzo(a)pyrene	99-122	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	10-13
4053018-7	1985	Intrinsic AHH activities were below the level of detection for all cell lines [less than 1 pmol of 3-hydroxybenzo(a)pyrene (3-OH-BP) formed per min per mg of protein].	3-hydroxybenzo(a)pyrene	124-131	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	10-13
4053018-8	1985	Treatment with benzanthracene resulted in AHH activities of 12 to 15 pmol of 3-OH-BP per min per mg of protein, but treatment with PB plus HC failed to induce significant AHH activities.	3-hydroxybenzo(a)pyrene	77-84	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	42-45
2866028-3	1985	Cytochrome P-450 dependent metabolism of benzo[a]pyrene, aldrin and ethoxyresorufin was 43-54% lower than in the parent cell suspension, glucuronidation of 3-hydroxybenzo[a]pyrene (3-OH-BP) and hydrolysis of styrene oxide were increased 1.5- and 1.4-fold, respectively.	3-hydroxybenzo(a)pyrene	181-188	cytochrome P450, family 2, subfamily g, polypeptide 1	Rattus norvegicus	0-16
3871719-11	1985	The profile of BaP metabolites showed a larger proportion of the BaP diols and 3-hydroxybenzo[a]pyrene, and a smaller proportion of BaP-4,5-epoxide and the BaP quinones, for the Brussels sprouts- and S. chinensis-fed groups.	3-hydroxybenzo(a)pyrene	79-102	prohibitin 2	Rattus norvegicus	15-18
6330212-5	1984	The basal activity (mean +/- SE) of AHH in normal epidermis was 62.1 +/- 5.6 units (fmol 3-hydroxybenzo[a]pyrene, 3-OH-BP/min/mg protein) whereas the activity in uninvolved skin of psoriatic individuals was 62.9 +/- 5.1 units (NS), Epoxide hydrolase activity was 25.1 +/- 1.1 (pmol BP 4,5-diol/min/mg protein) unites in normal epidermis and 24.8 +/- 2.1 units in epidermis from patients with psoriasis (NS).	3-hydroxybenzo(a)pyrene	89-112	aryl hydrocarbon receptor repressor	Homo sapiens	36-39
115836-3	1979	AHH activity is measured by conversion of benzo[a]pyrene (BP) to 3-hydroxy BP in homogenized cell extracts from control and treated cultures and is reported as pmol product formed/mg protein/min.	3-hydroxybenzo(a)pyrene	65-77	aryl hydrocarbon receptor repressor	Homo sapiens	0-3
6326392-1	1984	The mechanistic plurality of the microsomal cytochrome P-450 enzyme system is illustrated by studies of the oxidative metabolism of benzo[a]pyrene, 3-hydroxybenzo[a]pyrene and arachidonic acid.	3-hydroxybenzo(a)pyrene	148-171	cytochrome P450, family 2, subfamily g, polypeptide 1	Rattus norvegicus	44-60
6182644-1	1982	Administration of the carcinogens, benzo[a]pyrene and 1,2-benzanthracene, increased UDP glucuronosyltransferase activities towards 4-nitrophenol, 3-hydroxybenzo[a]pyrene, 7-hydroxycoumarin and 1-naphthol to a greater extent than did pretreatment with the noncarcinogens, anthracene and phenanthrene.	3-hydroxybenzo(a)pyrene	146-169	UDP glycosyltransferase 2 family, polypeptide B	Rattus norvegicus	84-111
28603847-3	2017	We report the functional and X-ray crystallographic analysis of 22F12 in complex with 3-hydroxybenzo[a]pyrene after cloning of the V-genes and production as a recombinant Fab fragment.	3-hydroxybenzo(a)pyrene	86-109	FA complementation group B	Homo sapiens	171-174
619459-1	1978	beta-Glucuronidase catalyzes the hydrolysis of benzo[a]pyrene-3-glucuronide to 3-hydroxybenzo[a]pyrene.	3-hydroxybenzo(a)pyrene	79-102	glucuronidase beta	Homo sapiens	0-18
30753342-6	2019	Concentrations of the peptidase kallikrein 13 (KLK13) showed significant positive associations with urinary concentrations of the PAH metabolites 3-hydroxybenzo[a]pyrene (3-OH-BaP) [B, 95% confidence interval (CI): 0.042, 0.008-0.076] and 3-hydroxybenzo[a]anthracene (3-OH-BaA) (B, 95% CI: 0.068, 0.002-0.134).	3-hydroxybenzo(a)pyrene	146-169	kallikrein related peptidase 13	Homo sapiens	32-45
30753342-6	2019	Concentrations of the peptidase kallikrein 13 (KLK13) showed significant positive associations with urinary concentrations of the PAH metabolites 3-hydroxybenzo[a]pyrene (3-OH-BaP) [B, 95% confidence interval (CI): 0.042, 0.008-0.076] and 3-hydroxybenzo[a]anthracene (3-OH-BaA) (B, 95% CI: 0.068, 0.002-0.134).	3-hydroxybenzo(a)pyrene	146-169	kallikrein related peptidase 13	Homo sapiens	47-52
30753342-6	2019	Concentrations of the peptidase kallikrein 13 (KLK13) showed significant positive associations with urinary concentrations of the PAH metabolites 3-hydroxybenzo[a]pyrene (3-OH-BaP) [B, 95% confidence interval (CI): 0.042, 0.008-0.076] and 3-hydroxybenzo[a]anthracene (3-OH-BaA) (B, 95% CI: 0.068, 0.002-0.134).	3-hydroxybenzo(a)pyrene	171-179	kallikrein related peptidase 13	Homo sapiens	32-45
30753342-6	2019	Concentrations of the peptidase kallikrein 13 (KLK13) showed significant positive associations with urinary concentrations of the PAH metabolites 3-hydroxybenzo[a]pyrene (3-OH-BaP) [B, 95% confidence interval (CI): 0.042, 0.008-0.076] and 3-hydroxybenzo[a]anthracene (3-OH-BaA) (B, 95% CI: 0.068, 0.002-0.134).	3-hydroxybenzo(a)pyrene	171-179	kallikrein related peptidase 13	Homo sapiens	47-52
30753342-7	2019	Moreover, dose-response relationships were observed between KLK13 and 3-OH-BaP (trend test P = 0.027) and 3-OH-BaA (P = 0.035).	3-hydroxybenzo(a)pyrene	70-78	kallikrein related peptidase 13	Homo sapiens	60-65
20055467-1	2010	The spectroscopic properties of a novel intramolecular energy transfer probe (ET probe)--consisting of 3-hydroxybenzo[a]pyrene (3OH-BaP) as the donor covalently linked to sulforhodamine B (SRB) as the acceptor--for the detection of polycyclic aromatic hydrocarbons (PAH) antibody binding were characterized.	3-hydroxybenzo(a)pyrene	103-126	chaperonin containing TCP1 subunit 4	Homo sapiens	189-192
20055467-1	2010	The spectroscopic properties of a novel intramolecular energy transfer probe (ET probe)--consisting of 3-hydroxybenzo[a]pyrene (3OH-BaP) as the donor covalently linked to sulforhodamine B (SRB) as the acceptor--for the detection of polycyclic aromatic hydrocarbons (PAH) antibody binding were characterized.	3-hydroxybenzo(a)pyrene	128-135	chaperonin containing TCP1 subunit 4	Homo sapiens	171-187
19922977-0	2010	1-Hydroxypyrene and 3-hydroxybenzo[a]pyrene as biomarkers of exposure to PAH in various environmental exposure situations.	3-hydroxybenzo(a)pyrene	20-43	phenylalanine hydroxylase	Homo sapiens	73-76
19526226-8	2009	This percutaneous first past effect of BaP in rats could, in part, explain the higher urinary excretion ratio of 3-OHBaP compared to the value based on intravenous administration of BaP.	3-hydroxybenzo(a)pyrene	113-120	prohibitin 2	Rattus norvegicus	39-42
19526226-9	2009	Conversely, BaP was largely lower metabolised as 3-OHBaP during percutaneous absorption by humans, so BaP absorption flux should be overestimated to a lesser extent in humans than in rats.	3-hydroxybenzo(a)pyrene	49-56	prohibitin 2	Homo sapiens	12-15
20599672-7	2010	3-Hydroxy-BaP was a prominent metabolite for all but CYP1D1.	3-hydroxybenzo(a)pyrene	0-13	cytochrome P450, family 1, subfamily D, polypeptide 1	Danio rerio	53-59